StockNews.com Begins Coverage on Athersys (NASDAQ:ATHX)

StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX) in a report issued on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.

Athersys Stock Down 33.5 %

NASDAQ:ATHX opened at $0.01 on Thursday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The stock has a market cap of $833,206.50, a PE ratio of -0.01 and a beta of -0.90.

Athersys Company Profile

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.